<?xml version="1.0" encoding="UTF-8"?>
<list>
  <sentences>
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="23424" end="23428" sStart="23288" offset="136" sid="r11.true.j.0573" wn="1" wnkey="true%3:00:00::" text="It is evident that genes containing a PPRE have roles in FA oxidation but not FA synthesis, whereas the converse is true for genes containing SRE promoters." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="70254" end="70260" sStart="null" offset="190" sid="r11.strong.j.0153" wn="1" wnkey="strong%3:00:00::" text="As another quality control measure, prior to hybridization with Affymetrix GeneChips (Affymetrix, Inc., Santa Clara, CA), we confirmed that pooled samples gave strong signals using Affymetrix test chips." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73863" end="73871" sStart="null" offset="43" sid="r11.refer.v.0908" wn="7" wnkey="refer%2:32:04::" text="Herein, absolute expression is referred to as average difference intensity (ADI) in all mathematical equations." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="81596" end="81602" sStart="null" offset="10" sid="r11.refer.v.0471" wn="6" wnkey="refer%2:32:00::" text="FUNG+FISH refers to the combination of fungal and fish oils fed together" />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="65317" end="65328" sStart="null" offset="237" sid="r11.recommend.v.0526" wn="1" wnkey="recommend%2:32:01::" text="The levels of AA and DHA chosen were similar to that previously shown in rats to affect neurotransmitter levels and behavior [ 96 ] ; and were not excessively high, being 2-3 fold higher than that recommended for human babies who have a slower ?6 desaturase activity than rodents." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="304" end="314" sStart="null" offset="88" sid="r10.particular.j.0229" wn="2147483647" wnkey="null" text="Studies have yet to resolve all the mechanisms of action of LC-PUFA, in particular the remarkable phenotypic differences between populations that consume different quantities of fish and fish oil in their diets [ 1 2 3 4 5 ] . Dietary LC-PUFA affect processes including: growth, neurological development, lean and fat mass accretion, reproduction, innate and acquired immunity, infectious pathologies of viruses, bacteria and parasites; and the incidence and severity of virtually all chronic and degenerative diseases including cancer, atherosclerosis, stroke, arthritis, diabetes, osteoporosis, and neurodegenerative, inflammatory, and skin diseases [ 6 7 8 9 10 11 ] . Due to lack of mechanistic knowledge, predictions for optimal intake of nutritionally important LC-PUFA remain vague and dietary recommendations simply relate to prevention of overt deficiency." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="60843" end="60849" sStart="null" offset="199" sid="r9.normal.j.0095" wn="1" wnkey="normal%3:00:01::" text="Feeding both LC-PUFA containing oils mimicked (or accentuated) the fasted metabolic state, confirming this aspect of the beneficial health effects of dietary LC-PUFA for both normal and clinical populations, and even household pets." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="60843" end="60849" sStart="null" offset="199" sid="r9.normal.j.0095" wn="3" wnkey="normal%3:00:03::" text="Feeding both LC-PUFA containing oils mimicked (or accentuated) the fasted metabolic state, confirming this aspect of the beneficial health effects of dietary LC-PUFA for both normal and clinical populations, and even household pets." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="60843" end="60849" sStart="null" offset="199" sid="r9.normal.j.0095" wn="1" wnkey="normal%3:00:01::" text="Feeding both LC-PUFA containing oils mimicked (or accentuated) the fasted metabolic state, confirming this aspect of the beneficial health effects of dietary LC-PUFA for both normal and clinical populations, and even household pets." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="60843" end="60849" sStart="null" offset="199" sid="r9.normal.j.0095" wn="2" wnkey="normal%3:00:02::" text="Feeding both LC-PUFA containing oils mimicked (or accentuated) the fasted metabolic state, confirming this aspect of the beneficial health effects of dietary LC-PUFA for both normal and clinical populations, and even household pets." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="32445" end="32449" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="Isoforms with specificity for short, medium, and &lt;b&gt;long&lt;/b&gt; chain FA exist." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73" end="77" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="The presence and abundance of &lt;b&gt;long&lt;/b&gt; chain polyunsaturated fatty acids (LC-PUFA) in humans diets have been the basis of scientific investigations for decades." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="45545" end="45549" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="CD36 protein mediates &lt;b&gt;long&lt;/b&gt; chain free FA uptake in adipocytes and other tissues, including liver." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="45707" end="45711" sStart="null" offset="0" sid="null" wn="" wnkey="null" text="In murine pre-adipocytes, it is transcriptionally up regulated by &lt;b&gt;long&lt;/b&gt; chain free FAs via a PPAR?-mediated process [ 66 ] . Approaches using antisense technology, null mice, transgenic mice, and microarrays revealed important additional roles of CD36 protein as a receptor for thrombospondin, collagen type I, and oxidized LDL on macrophages [ 67 ] . The up regulation of Cd36 with FISH, and antagonism in presence of FUNG, merits further study." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="32445" end="32449" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="Isoforms with specificity for short, medium, and &lt;b&gt;long&lt;/b&gt; chain FA exist." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73" end="77" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="The presence and abundance of &lt;b&gt;long&lt;/b&gt; chain polyunsaturated fatty acids (LC-PUFA) in humans diets have been the basis of scientific investigations for decades." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="45545" end="45549" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="CD36 protein mediates &lt;b&gt;long&lt;/b&gt; chain free FA uptake in adipocytes and other tissues, including liver." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="45707" end="45711" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="In murine pre-adipocytes, it is transcriptionally up regulated by &lt;b&gt;long&lt;/b&gt; chain free FAs via a PPAR?-mediated process [ 66 ] . Approaches using antisense technology, null mice, transgenic mice, and microarrays revealed important additional roles of CD36 protein as a receptor for thrombospondin, collagen type I, and oxidized LDL on macrophages [ 67 ] . The up regulation of Cd36 with FISH, and antagonism in presence of FUNG, merits further study." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="81743" end="81747" sStart="null" offset="0" sid="null" wn="2" wnkey="long%3:00:01::" text="LC-PUFA &lt;b&gt;long&lt;/b&gt; chain polyunsaturated fatty acid" />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="1" wnkey="level%1:07:00::" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="3" wnkey="level%1:26:00::" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="1" wnkey="level%1:07:00::" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="1" wnkey="level%1:07:00::" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="22523" end="22529" sStart="null" offset="83" sid="r9.level.n.0648" wn="2" wnkey="level%1:26:01::" text="An increase in transcription of SREBP-1 may be associated with increased levels of the active SREBP-1 protein." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="" wnkey="null" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29983" end="29989" sStart="null" offset="276" sid="null" wn="2" wnkey="level%1:26:01::" text="Although ACC was not regulated at the transcriptional level, cytoplasmic citrate (generated from the Acly reaction) is an allosteric activator of ACC, so less cytoplasmic citrate would lead to less activation of ACC [ 45 ] . Transcript levels of hepatic acetyl CoA synthetase 1 AMP forming (acetate:CoA ligase AMP forming; Acas1) were consistently down regulated by LC-PUFA (-2." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47615" end="47620" sStart="null" offset="0" sid="null" wn="4" wnkey="know%2:31:00::" text="N3 LC-PUFA, particularly 20:5n3, are &lt;b&gt;known&lt;/b&gt; to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47615" end="47620" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="N3 LC-PUFA, particularly 20:5n3, are &lt;b&gt;known&lt;/b&gt; to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47615" end="47620" sStart="null" offset="0" sid="null" wn="9" wnkey="know%2:31:11::" text="N3 LC-PUFA, particularly 20:5n3, are &lt;b&gt;known&lt;/b&gt; to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47615" end="47620" sStart="null" offset="0" sid="null" wn="1" wnkey="know%2:31:01::" text="N3 LC-PUFA, particularly 20:5n3, are &lt;b&gt;known&lt;/b&gt; to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="file:/c:/OANC/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47615" end="47620" sStart="null" offset="0" sid="null" wn="2147483645" wnkey="null" text="N3 LC-PUFA, particularly 20:5n3, are &lt;b&gt;known&lt;/b&gt; to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="65269" end="65273" sStart="null" offset="189" sid="r10.high.j.0700" wn="1" wnkey="high%3:00:02::" text="The levels of AA and DHA chosen were similar to that previously shown in rats to affect neurotransmitter levels and behavior [ 96 ] ; and were not excessively high, being 2-3 fold higher than that recommended for human babies who have a slower ?6 desaturase activity than rodents." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="11240" end="11244" sStart="null" offset="14" sid="r10.high.j.0296" wn="1" wnkey="high%3:00:02::" text="The high degree of concordance between RT-PCR and microarray data (86%- reported in detail elsewhere [ 27 ] ) establishes a certain level of confidence in the results discussed throughout this manuscript." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="13541" end="13550" sStart="null" offset="11" sid="r11.function.n.0583" wn="3" wnkey="function%1:04:00::" text="The tissue functions were reflected in the transcriptomic profile." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73972" end="73980" sStart="null" offset="4" sid="r11.function.n.0986" wn="2" wnkey="function%1:07:00::" text="The function describing the upper 5% of hippocampal and liver data was described with the following equations: LFC hippocampus = 1.36 + (90/min ADI); and LFC liver = 1.52+(100/min ADI), respectively." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="46579" end="46587" sStart="null" offset="213" sid="r11.function.n.0720" wn="2" wnkey="function%1:07:00::" text="E-FABP is found in liver and other organs [ 68 ] , but it has been most studied in psoriatic skin lesions [ 69 ] where it has putative roles in FA cytoplasmic transport, skin barrier function and keratinocyte differentiation [ 70 ] . Although links between PPARs and E-FABP have not currently been identified, this gene clustered with other known PPAR-affected genes suggesting a possibly important regulatory link." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73566" end="73570" sStart="null" offset="257" sid="r9.fold.v.0717" wn="2147483645" wnkey="null" text="This method moves beyond setting a single fold change cut-off by considering fold change in the context of absolute expression [ 27 ] . In brief, this method includes: (A) the determination of the upper 5% of fold changes within narrow bins of absolute expression levels to determine a limit fold change (LFC) function; and (B) subsequent ranking of genes by a combined fold change/absolute difference calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="10537" end="10541" sStart="null" offset="16" sid="r9.fold.v.0553" wn="2147483645" wnkey="null" text="Those fold changes that are significant by the 5% LFC model are further identified with an asterisk (*)." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="34516" end="34520" sStart="null" offset="3" sid="r9.fold.v.0449" wn="2147483645" wnkey="null" text="9* fold with the combination diet (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="10919" end="10923" sStart="null" offset="273" sid="r9.fold.v.0445" wn="2147483645" wnkey="null" text="It is important to note that the nature of the LFC model allows differentially expressed genes to be selected based on differences between the treatments, and therefore explains why some genes discussed in the text have no fold changes marked with an asterisk (as significance was observed between treatments and not versus the control diet)." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="9230" end="9234" sStart="null" offset="103" sid="r9.fold.v.0078" wn="2147483645" wnkey="null" text="Differentially expressed genes induced by the dietary treatments were selected using a limit fold change (LFC) model, in addition to a more conventional confidence interval test [ 27 ] . Genes that satisfied the 5% LFC model and which lay above the 99." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="46887" end="46891" sStart="null" offset="25" sid="r9.fold.v.0787" wn="2147483645" wnkey="null" text="Purified E-FABP has five fold higher affinity for 18:0, than for 18:1n9 and 20:4n6 (22:6n3 not studied) [ 69 ] . Herein, hepatic E-FABP expression (Fabp5 transcript) was down regulated by all three diets (-5." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="65285" end="65289" sStart="null" offset="205" sid="r9.fold.v.0503" wn="2147483645" wnkey="null" text="The levels of AA and DHA chosen were similar to that previously shown in rats to affect neurotransmitter levels and behavior [ 96 ] ; and were not excessively high, being 2-3 fold higher than that recommended for human babies who have a slower ?6 desaturase activity than rodents." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="73410" end="73414" sStart="null" offset="101" sid="r9.fold.v.0375" wn="2147483645" wnkey="null" text="This method moves beyond setting a single fold change cut-off by considering fold change in the context of absolute expression [ 27 ] . In brief, this method includes: (A) the determination of the upper 5% of fold changes within narrow bins of absolute expression levels to determine a limit fold change (LFC) function; and (B) subsequent ranking of genes by a combined fold change/absolute difference calculation." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="9230" end="9234" sStart="null" offset="103" sid="r9.fold.v.0078" wn="2147483645" wnkey="null" text="Differentially expressed genes induced by the dietary treatments were selected using a limit fold change (LFC) model, in addition to a more conventional confidence interval test [ 27 ] . Genes that satisfied the 5% LFC model and which lay above the 99." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="37271" end="37275" sStart="null" offset="82" sid="r9.fold.v.0908" wn="2147483645" wnkey="null" text="Feeding of all three LC-PUFA diets led to an approximately 2* fold increase in hepatic Pck1 for each probe set identified." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="27959" end="27963" sStart="null" offset="82" sid="r9.fold.v.0900" wn="2147483645" wnkey="null" text="HNF3?-signaling may regulate transcription of Pck1 (up regulated ca. 2* fold with each diet, presently), and G6pc (differentially regulated in the current experiment) [ 42 ] . HNF3? is also reported to increase transcription of several genes that were not differentially regulated in the present experiment including, transferrin, tyrosine amino transferase [ 43 ] , and IPF-1/PDX-1 [ 40 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="19498" end="19502" sStart="null" offset="80" sid="r9.fold.v.0868" wn="2147483645" wnkey="null" text="Genes such as Cd36, Cyp2b9, Hmgcs2, and Ech1 were induced more than 4-fold when Wy-14,643 (a PPAR?-specific agonist) was administered to mice for 2 weeks." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="32135" end="32139" sStart="null" offset="75" sid="r9.fold.v.0828" wn="2147483645" wnkey="null" text="For example, Crat expression was significantly up regulated 3.3* fold with FISH treatment, but was less effected with FUNG and the combination diet." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="81799" end="81803" sStart="null" offset="10" sid="r9.fold.v.0696" wn="2147483645" wnkey="null" text="LFC limit fold change" />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="55262" end="55266" sStart="null" offset="137" sid="r9.fold.v.0636" wn="2147483645" wnkey="null" text="Similar to our findings in mice, feeding rats fish oil significantly decreased Ttr expression in whole brain 2.9 fold [ 18 ] . Interestingly, feeding of" />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="9230" end="9234" sStart="null" offset="103" sid="r9.fold.v.0078" wn="2147483645" wnkey="null" text="Differentially expressed genes induced by the dietary treatments were selected using a limit fold change (LFC) model, in addition to a more conventional confidence interval test [ 27 ] . Genes that satisfied the 5% LFC model and which lay above the 99." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="36628" end="36632" sStart="null" offset="3" sid="r9.fold.v.0786" wn="" wnkey="null" text="6* fold with FISH alone." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="27458" end="27462" sStart="null" offset="3" sid="r9.fold.v.0382" wn="" wnkey="null" text="0* fold with FUNG+FISH, but not with the individual LC-PUFA." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="10321" end="10325" sStart="null" offset="109" sid="r9.fold.v.0106" wn="" wnkey="null" text="In the present document, genes that are discussed are followed by parentheses indicating fold changes according to the following convention: FUNG versus control diet, FISH versus control diet, and FUNG+FISH versus control diet, e.g." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="9230" end="9234" sStart="null" offset="103" sid="r9.fold.v.0078" wn="2147483645" wnkey="null" text="Differentially expressed genes induced by the dietary treatments were selected using a limit fold change (LFC) model, in addition to a more conventional confidence interval test [ 27 ] . Genes that satisfied the 5% LFC model and which lay above the 99." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="22198" end="22203" sStart="null" offset="7" sid="r10.find.v.0717" wn="4" wnkey="find%2:32:00::" text="[ 34 ] found AA to be more potent than DHA (saturated and monounsaturated being ineffective) at inhibiting activation of SREBP-1c promoter and LXRE enhancer constructs, induced by co-expression of LXR? or -?." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="19242" end="19247" sStart="null" offset="355" sid="r10.find.v.0770" wn="2" wnkey="find%2:39:02::" text="A recent study examined effects of PPAR?-specific induction in murine livers using cDNA microarrays [ 30 ] . Despite the different strain of mice examined (C57BL/6J) and the different genomic technology utilized for the examination of differentially expressed genes (cDNA microarrays), several genes were found differentially regulated in both experiments, indicating that the PPAR agonist and LC-PUFA affect gene expression through similar pathways." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="35097" end="35102" sStart="null" offset="62" sid="r10.find.v.0658" wn="1" wnkey="find%2:40:02::" text="cAMP is an important signaling molecule that can be found in specific cellular domains [ 53 ] . Levels are controlled through synthesis via adenylate cyclase, and degradation via phosphodiesterases (PDEs)." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="19028" end="19037" sStart="null" offset="141" sid="r8.1.different.j.0484" wn="2" wnkey="different%5:00:00:other:00" text="A recent study examined effects of PPAR?-specific induction in murine livers using cDNA microarrays [ 30 ] . Despite the different strain of mice examined (C57BL/6J) and the different genomic technology utilized for the examination of differentially expressed genes (cDNA microarrays), several genes were found differentially regulated in both experiments, indicating that the PPAR agonist and LC-PUFA affect gene expression through similar pathways." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="63181" end="63190" sStart="null" offset="10" sid="r8.1.different.j.0647" wn="1" wnkey="different%3:00:00::" text="Secondly, different transcription factors exist and were activated in the two organs, which would affect downstream signaling." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="394" end="403" sStart="null" offset="178" sid="r8.1.different.j.0531" wn="1" wnkey="different%3:00:00::" text="Studies have yet to resolve all the mechanisms of action of LC-PUFA, in particular the remarkable phenotypic differences between populations that consume different quantities of fish and fish oil in their diets [ 1 2 3 4 5 ] . Dietary LC-PUFA affect processes including: growth, neurological development, lean and fat mass accretion, reproduction, innate and acquired immunity, infectious pathologies of viruses, bacteria and parasites; and the incidence and severity of virtually all chronic and degenerative diseases including cancer, atherosclerosis, stroke, arthritis, diabetes, osteoporosis, and neurodegenerative, inflammatory, and skin diseases [ 6 7 8 9 10 11 ] . Due to lack of mechanistic knowledge, predictions for optimal intake of nutritionally important LC-PUFA remain vague and dietary recommendations simply relate to prevention of overt deficiency." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="66573" end="66577" sStart="null" offset="126" sid="r11.dark.j.0470" wn="1" wnkey="dark%3:00:01::" text="Food was not removed the night before, and since nocturnal mice are known to eat during the normal period dark cycle employed, the mice could have been fasted 0-6 h at sacrifice." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="68722" end="68729" sStart="null" offset="87" sid="r10.control.n.0781" wn="4" wnkey="control%1:09:02::" text="Secondly, a separate piece of liver was excised from three of the individual control mice ( n = 3) to additionally and independently extract a second set of RNA; these three mice were chosen at random from the group of five." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="6049" end="6056" sStart="null" offset="81" sid="r10.control.n.0321" wn="3" wnkey="control%1:04:02::" text="Diets were fed for 57 days to study chronic and sustained alterations in control of gene expression rather than acute effects." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="10421" end="10428" sStart="null" offset="209" sid="r10.control.n.0165" wn="4" wnkey="control%1:09:02::" text="In the present document, genes that are discussed are followed by parentheses indicating fold changes according to the following convention: FUNG versus control diet, FISH versus control diet, and FUNG+FISH versus control diet, e.g." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="52747" end="52754" sStart="null" offset="148" sid="r10.control.n.0492" wn="3" wnkey="control%1:04:02::" text="Additionally, there were numerous ontological assignments for genes which suggested dietary LC-PUFA feeding affected cell cycle control including the following categories: &quot;cytoskeleton, cell cycle control, and cell cycle regulator&quot;." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="70802" end="70810" sStart="null" offset="13" sid="r10.control.n.0138" wn="4" wnkey="control%1:09:02::" text="Pooled liver controls were evaluated in duplicate on the Affymetrix probe array cartridge to estimate experimental variation in gene chip hybridization, as previously described in detail [ 27 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="58825" end="58836" sStart="null" offset="515" sid="r11.combination.n.0415" wn="1" wnkey="combination%1:14:00::" text="POMC is cleaved post-translationally producing bioactive peptides (adrenocorticotrophin, ?-endorphin and ?-, ?- and ?-melanocyte stimulating hormones) that interact with neurons expressing melanocortin receptors, leading to appetite suppression [ 91 ] . Feeding high fat diets is known to increase Pomc expression [ 92 ] . Herein, FUNG feeding resulted in a 6.0* fold increase in hippocampal Pomc, whereas FISH and the combination diet had smaller, non-statistically significant effects (6." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29389" end="29400" sStart="null" offset="137" sid="r11.combination.n.0283" wn="1" wnkey="combination%1:14:00::" text="4*; FUNG and FISH were not statistically significant from one another, but each was significantly different with the combination diet)." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="42837" end="42848" sStart="null" offset="241" sid="r11.combination.n.0253" wn="1" wnkey="combination%1:14:00::" text="8*), consistent with some of the lipid data described below; whereas the probe set for Elovl3 was not affected by FUNG, up regulated with FISH, and down regulated, although not significantly, with the combination diet (-1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="25604" end="25615" sStart="null" offset="273" sid="r11.combination.n.0190" wn="1" wnkey="combination%1:14:00::" text="For example, both upstream stimulating factor (USF; an E-box binding factor) and SREBP bind the FA synthase (Fasn) E-box [ 38 ] . Hepatic Usf2 transcription was significantly down regulated with FISH, but not affected by FUNG or the combination diet using microarrays, but this result could not fully be confirmed using RT-PCR (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="81610" end="81621" sStart="null" offset="24" sid="r11.combination.n.0827" wn="1" wnkey="combination%1:14:00::" text="FUNG+FISH refers to the combination of fungal and fish oils fed together" />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="29525" end="29536" sStart="null" offset="117" sid="r11.combination.n.0524" wn="1" wnkey="combination%1:14:00::" text="It is intriguing that, in general, both Acly and Fasn were more strongly down regulated with the combination diet than the individual LC-PUFA." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="55061" end="55072" sStart="null" offset="106" sid="r11.combination.n.0515" wn="1" wnkey="combination%1:14:00::" text="Dietary FISH had the effect of decreasing Ttr; whereas, FUNG and particularly the combination diet, increased Ttr (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="32211" end="32222" sStart="null" offset="151" sid="r11.combination.n.0419" wn="1" wnkey="combination%1:14:00::" text="For example, Crat expression was significantly up regulated 3.3* fold with FISH treatment, but was less effected with FUNG and the combination diet." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47917" end="47928" sStart="null" offset="116" sid="r11.combination.n.0161" wn="1" wnkey="combination%1:14:00::" text="Mitochondrial Hmgcs2, which is involved in ketogenesis, was up regulated, particularly with the combination diet (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="49715" end="49726" sStart="null" offset="75" sid="r11.combination.n.0897" wn="7" wnkey="combination%1:04:00::" text="FUNG and FISH alone moderately down regulated Apoa4, whereas the combination diet resulted in a large down regulation (-2." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="34530" end="34541" sStart="null" offset="17" sid="r11.combination.n.0567" wn="7" wnkey="combination%1:04:00::" text="9* fold with the combination diet (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="56734" end="56745" sStart="null" offset="94" sid="r11.combination.n.0480" wn="7" wnkey="combination%1:04:00::" text="Hippocampal ?-2,8-sialyltransferase (Siat8e) was down regulated with FISH and the combination diet, but not with FUNG; difference relative to control was only significant for the combination diet (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="32577" end="32588" sStart="null" offset="111" sid="r11.combination.n.0246" wn="7" wnkey="combination%1:04:00::" text="Medium-chain acyl-Coenzyme A dehydrogenase (Acadm) was up regulated, particularly with the combination diet (1." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47317" end="47328" sStart="null" offset="126" sid="r11.combination.n.0138" wn="1" wnkey="combination%1:14:00::" text="The significance of this large decrease in hepatic expression by both FUNG and FISH, and particularly the combination of the two, is a potentially important finding whose physiological consequence must be further investigated." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="47649" end="47656" sStart="null" offset="71" sid="r11.benefit.n.0895" wn="2" wnkey="benefit%1:07:00::" text="N3 LC-PUFA, particularly 20:5n3, are known to be of clinical benefit in treating psoriasis [ 71 ] ." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="24013" end="24019" sStart="null" offset="168" sid="r9.appear.v.0683" wn="4" wnkey="appear%2:39:01::" text="Overall, the number of regulated genes with SREs and PPREs indicates the breadth of molecular responses to dietary LC-PUFA, many of which appear to be co-orchestrated not only by these two transcription factors, but by additional elements as well." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="24345" end="24351" sStart="null" offset="50" sid="r9.appear.v.0216" wn="1" wnkey="appear%2:39:00::" text="Thus, chronic AA feeding alone does not appear, in our experiments, to interact with the SREBP-1 signaling cascade." />
    <s path="[OANC]/data/written_2/technical/biomed/1476-511X-1-2.anc" start="76404" end="76411" sStart="null" offset="0" sid="r11.absence.n.0737" wn="1" wnkey="absence%1:26:00::" text="Absence/presence calls were not considered a priori in selecting significantly regulated genes, but were a post-selection criterion." />
  </sentences>
</list>